Optimi Health completes harvest of Psilocybe cubensis
VANCOUVER – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) , an end-to-end drug researcher and formulator licensed by Health Canada to produce and supply, for clinical research purposes and in controlled patient markets, psychedelic substances such as 3,4-Methylenedioxymethamphetamine (MDMA), GMP-grade psilocybin, along with natural health product formulations, announced the completion of its harvest of Psilocybe cubensis earmarked for export to...
Read More
